Skip to main content
. 2019 May 6;11(9):2628–2652. doi: 10.18632/aging.101934

Figure 4.

Figure 4

Prognostic value of PIEZO2 (Affymetrix ID are valid: 1562488_at and 222908_at) in breast cancer patients. (A-B) Overall survival curve of PIEZO2 for breast cancer patients; (C-D) relapse free survival curve of PIEZO2 for breast cancer patients; (E-F) distant metastases free survival curve of PIEZO2 for breast cancer patients; (G-H) post progression survival curve of PIEZO2 for breast cancer patients.